ArticleInternational journal of hematology2020

Comprehensive analyses of safety and efficacy toward individualizing imatinib dosage in patients with chronic myeloid leukemia.

Hyejin Shin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.